{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:32:45Z","timestamp":1759451565387,"version":"build-2065373602"},"reference-count":27,"publisher":"Informa UK Limited","issue":"10","funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-059"],"award-info":[{"award-number":["2022-PUMCH-B-059"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["CIFMS 2021-I2M-1-003"],"award-info":[{"award-number":["CIFMS 2021-I2M-1-003"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2025,10,3]]},"DOI":"10.1080\/14740338.2024.2392885","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T05:55:38Z","timestamp":1723614938000},"page":"1157-1163","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Real-world safety profile of eculizumab: an analysis of FDA adverse event reporting system and systematic review of case reports"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5417-3463","authenticated-orcid":false,"given":"Zhihui","family":"Zhang","sequence":"first","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]},{"name":"Peking Union Medical College Hospital","place":["Beijing, China"]},{"name":"Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]},{"name":"Peking Union Medical College Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]},{"name":"Peking Union Medical College Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.10.015"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25640"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.4694"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000279"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6627e1"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2022.2054986"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-019-00341-2"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.862508"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14868"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2204227"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.677"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.668"},{"volume-title":"LiverTox: clinical and research information on drug-induced liver injury [Internet]","year":"2012","key":"e_1_3_5_14_1","unstructured":"Adverse drug reaction probability scale (Naranjo) in drug induced liver injury. In: LiverTox: clinical and research information on drug-induced liver injury [Internet]. (Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012 [cited2019 May 4]. PMID: 31689026."},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2014.10.010"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-3503"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S257009"},{"issue":"17","key":"e_1_3_5_19_1","first-page":"5","article-title":"Ya bing Xing, Meng Lv. Literature analysis of infectious adverse reactions induced byeculizumab","volume":"42","author":"Hai L","year":"2022","unstructured":"Hai L, Li T. Ya bing Xing, Meng Lv. Literature analysis of infectious adverse reactions induced byeculizumab. Chin J Hosp Pharm. 2022;42(17):5.","journal-title":"Chin J Hosp Pharm"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/23247096211012194"},{"issue":"1","key":"e_1_3_5_21_1","first-page":"209","article-title":"Disseminated gonococcal infection","volume":"45","author":"Kerle KK","year":"1992","unstructured":"Kerle KK, Mascola JR, Miller TA. Disseminated gonococcal infection. Am Fam Physician. 1992 Jan;45(1):209\u2013214.","journal-title":"Am Fam Physician"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy958"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30930-0"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1713111"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-019-04234-6"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12890"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-141636"},{"issue":"3","key":"e_1_3_5_28_1","first-page":"6","article-title":"Literature analysis of non-infectious adverse reactions induced by eculizumab","volume":"42","author":"Hai L","year":"2022","unstructured":"Hai L, Lv M, Li T, et al. Literature analysis of non-infectious adverse reactions induced by eculizumab. Chin J Hosp Pharm. 2022;42(3):6.","journal-title":"Chin J Hosp Pharm"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2024.2392885","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T07:12:59Z","timestamp":1759389179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2024.2392885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,3]]}},"alternative-id":["10.1080\/14740338.2024.2392885"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2024.2392885","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"type":"print","value":"1474-0338"},{"type":"electronic","value":"1744-764X"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}